News about "Mirvetuximab Soravtansine "

AbbVie Gets Positive CHMP Opinion for Mirvetuximab Soravtansine

AbbVie Gets Positive CHMP Opinion for Mirvetuximab Soravtansine

AbbVie has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authorization of mirvetuximab soravtansine (ELAHERE).

Mirvetuximab Soravtansine | 21/09/2024 | By Aishwarya 114


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members